|
1
|
Pittenger MF, Mackay AM, Beck SC, Jaiswal
RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and
Marshak DR: Multilineage potential of adult human mesenchymal stem
cells. Science. 284:142–147. 1999. View Article : Google Scholar
|
|
2
|
Phinney DG and Prockop DJ: Concise review:
Mesenchymal stem/multipotent stromal cells: The state of
transdifferentiation and modes of tissue repair-current views. Stem
Cells. 25:2896–2902. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bassi EJ, Aita CA and Camara NO: Immune
regulatory properties of multipotent mesenchymal stromal cells:
Where do we stand? World J Stem Cell. 3:1–8. 2011. View Article : Google Scholar
|
|
4
|
Shi M, Liu ZW and Wang FS:
Immunomodulatory properties and therapeutic application of
mesenchymal stem cells. Clin Exp Immunol. 164:1–8. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sensebe L, Krampera M, Schrezenmeier H,
Bourin P and Giordano R: Mesenchymal stem cells for clinical
application. Vox Sang. 98:93–107. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sun L, Wang D, Liang J, Zhang H, Feng X,
Wang H, Hua B, Liu B, Ye S, Hu X, et al: Umbilical cord mesenchymal
stem cell transplantation in severe and refractory systemic lupus
erythematosus. Arthritis Rheum. 62:2467–2475. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang HS, Shu JF, Shen WS, Hsu HC, Chi TC,
Chen CP, Huang SW, Shyr YM, Tang KT and Chen TH: Transplantation of
insulin-producing cells derived from umbilical cord stromal
mesenchymal stem cells to treat NOD mice. Cell Trnsplant.
20:455–466. 2011. View Article : Google Scholar
|
|
8
|
Zhang Z, Lin H, Shi M, Xu R, Fu J, Lv J,
Chen L, Lv S, Li Y, Yu S, et al: Human umbilical cord mesenchymal
stem cells improve liver function and ascites in decompensated
liver cirrhosis patients. J Gastroenterol Hepaol. 27 Suppl
2:S112–S120. 2012. View Article : Google Scholar
|
|
9
|
Wang J, Yin Z, Wen H, Wang L and Chen Z:
Application of umbilical cord mesenchymal stem cells in cerebral
palsy treatment: Report of 51 cases. Chinse Gen Pract.
14:2446–2447. 2011.
|
|
10
|
Liu Y, Mu R, Wang S, Long L, Liu X, Li R,
Sun J, Guo J, Zhang X, Guo J, et al: Therapeutic potential of human
umbilical cord mesenchymal stem cells in the treatment of
rheumatoid arthritis. Arthritis Res Ther. 12:R2102010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ma Y, Hao X, Zhang S and Zhang J: The in
vitro and in vivo effects of human umbilical cord mesenchymal stem
cells on the growth of breast cancer cells. Breast Cancer Res
Treat. 133:473–485. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Matsuzuka T, Rachakatla RS, Doi C, Maurya
DK, Ohta N, Kawabata A, Pyle MM, Pickel L, Reischman J, Marini F,
et al: Human umbilical cord matrix-derived stem cells expressing
interferon-beta gene significantly attenuate bronchioloalveolar
carcinoma xenografts in SCID mice. Lung Cancer. 70:28–36. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kabashima-Niibe A, Higuchi H, Takaishi H,
Masugi Y, Matsuzaki Y, Mabuchi Y, Funakoshi S, Adachi M, Hamamoto
Y, Kawachi S, et al: Mesenchymal stem cells regulate
epithelial-mesenchymal transition and tumor progression of
pancreatic cancer cells. Cancer Sci. 104:157–164. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang T, Lee YW, Rui YF, Cheng TY, Jiang
XH and Li G: Bone marrow-derived mesenchymal stem cells promote
growth and angiogenesis of breast and prostate tumors. Stem Cell
Res Ther. 4:702013. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang Y, Wang Y, Li L, Chen F and Zhang P:
Activation of the Toll-like receptor 8 pathway increases the
immunogenicity of mesenchymal stem cells from umbilical cord. Mol
Med Rep. 16:2061–2068. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Thiery JP: Epithelial-mesenchymal
transition in tumor progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu J, Han GQ, Liu H and Qin C:
Suppression of cholangiocarcinoma cell growth by human umbilical
cord mesenchyaml stem cells: A possible role of wnt and Akt
signaling. PLoS One. 8:e628442013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Y, Fan H, Zhou B, Ju Z, Yu L, Guo L,
Han J and Lu S: Fusion of human umbilical cord mesenchymal stem
cells with esophageal carcinoma cells inhibits the tumorigenecity
of esophageal carcinoma cells. Int J Oncol. 40:370–377.
2012.PubMed/NCBI
|
|
20
|
Sun XY, Nong J, Qin K, Lu H, Moniri MR,
Dai LJ and Warnock GL: MSC (TRAIL)-mediated HepG2 cell death in
direct and indirect co-culture. Anticancer Res. 31:3705–3712.
2011.PubMed/NCBI
|
